Study Of 323U66 SR In Major Depressive Disorder
Depressive Disorder
About this trial
This is an interventional treatment trial for Depressive Disorder focused on measuring MDD
Eligibility Criteria
Inclusion criteria: Met DSM-IV-TR criteria for major depressive disorder for their current episode for at least 8 weeks prior to screening visit. Must give a written informed consent. But if the patient is under 20, both the patient himself/herself and his/her proxy consenter must give written informed consent. Must have rating scores as outlined. Exclusion criteria: Current or past history of seizure disorder or brain injury. Current or past history of anorexia or bulimia nervosa. History of manic episode. Past or current DSM- IV-TR diagnosis of schizophrenia or other psychotic disorder. Diagnosis of substance abuse (alcohol or drug) by the DSM-IV-TR criteria. Pregnant, possibly pregnant or lactating. Must not be suicidal. Blood pressure of SBP>160mmHg, DBP>100mmHg. History or complication of cancer or malignant tumour.
Sites / Locations
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site